SEC Form 4 · accession 0001209191-17-037322
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Medel M.D.
Officer — Chief Executive Officer · Director
Period of report
Feb 13, 2017
Accepted (ET)
Jun 2, 2017 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2017 | G | 16,020 | $0.00 | D | 1,233,304 | D | |
| Common StockF2 | Jun 1, 2017 | A | 110,532 | $0.00 | A | 1,343,836 | D | |
| Common StockF3 | Jun 1, 2017 | F | 38,257 | $0.00 | D | 1,288,739 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition pursuant to a gift to a charitable institute.
- F2Restricted shares granted pursuant to the Issuer's Amended and Restate 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 27,633 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
- F3Reflects a reduction of 16,840 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment.